骨髓活检在诊断慢性再障和骨髓增生异常综合征中的价值  

Evaluation of Bone Marrow Biopsy in the Diagnosis of CAA and MDS

作　　者：张世蔚[1] 康小强[1] 陈炳珍[1] 钱世玲 舒江桥[2] 刘有芳[2] 

机构地区：[1]同济医科大学附属协和医院血液科 [2]同济医科大学附属协和医院病理科

出　　处：《同济医科大学学报》1989年第A01期12-13,71,共2页Acta Universitatis Medicinae Tongji

摘　　要：本文报道骨髓活检慢性再障16例和MDS9例,根据骨髓组织的造血细胞增生程度、细胞成分和其它组织变化,有助于诊断和鉴别这两种疾病;骨髓活检诊断慢性再障有重要价值。The results of bone marrow biopsy from 16 cases of CAA and 9 cases of MDS were reported in this article. It was found that CAA and MDS could be correctly diagnosed and CAA could be differentiated from MDS according to their respective bone marrow proliferative degree, hcmopoietic component and other bone marrow pathological changes. To sum up, bone marrow biopsy is of value in the diagnosis of CAA. So far no report has ever been published in the literature on differentiation between these two diseases by the use of bone marrow biopsy.

关 键 词：骨髓活检 再生障碍性 贫血 MDS 

分 类 号：R556.504[医药卫生—血液循环系统疾病]